[go: up one dir, main page]

CA3018991C - Composes induisant la degradation de proteines anti-apoptotiques de la famille bcl-2 et utilisation de ces derniers - Google Patents

Composes induisant la degradation de proteines anti-apoptotiques de la famille bcl-2 et utilisation de ces derniers

Info

Publication number
CA3018991C
CA3018991C CA3018991A CA3018991A CA3018991C CA 3018991 C CA3018991 C CA 3018991C CA 3018991 A CA3018991 A CA 3018991A CA 3018991 A CA3018991 A CA 3018991A CA 3018991 C CA3018991 C CA 3018991C
Authority
CA
Canada
Prior art keywords
compound
bcl
bond
linker
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3018991A
Other languages
English (en)
Other versions
CA3018991A1 (fr
Inventor
Guangrong Zheng
Daohong Zhou
Xuan Zhang
Yingying Wang
Jianhui Chang
Original Assignee
BioVentures LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioVentures LLC filed Critical BioVentures LLC
Priority claimed from PCT/US2017/028875 external-priority patent/WO2017184995A1/fr
Publication of CA3018991A1 publication Critical patent/CA3018991A1/fr
Application granted granted Critical
Publication of CA3018991C publication Critical patent/CA3018991C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des compositions et des méthodes permettant de détruire sélectivement des cellules sénescentes, la composition comprenant un composé de Formule (I) ou un composé de Formule (II). La destruction sélective de cellules sénescentes pourrait retarder le vieillissement et/ou traiter des troubles liés à l'âge.
CA3018991A 2016-04-21 2017-04-21 Composes induisant la degradation de proteines anti-apoptotiques de la famille bcl-2 et utilisation de ces derniers Active CA3018991C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662325856P 2016-04-21 2016-04-21
US62/325,856 2016-04-21
PCT/US2017/028875 WO2017184995A1 (fr) 2016-04-21 2017-04-21 Composés induisant la dégradation de protéines anti-apoptotiques de la famille bcl-2 et utilisation de ces derniers

Publications (2)

Publication Number Publication Date
CA3018991A1 CA3018991A1 (fr) 2017-10-26
CA3018991C true CA3018991C (fr) 2026-01-27

Family

ID=

Similar Documents

Publication Publication Date Title
US11319316B2 (en) Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
EP3743069B1 (fr) Agents de dégradation de protéines bcl-2 pour le traitement du cancer
US20190054097A1 (en) Compositions targeting senescent cells and the uses thereof
US20180369223A1 (en) Compositions and methods for selectively depleting senescent cells
US10905665B2 (en) Chemical modulators of signaling pathways and therapeutic use
JP6630364B2 (ja) 水溶性プロドラッグ
US12084423B2 (en) Piperlongumine analogues and uses thereof
WO2011104266A1 (fr) Inhibiteurs dimères d'iap
CA3028122A1 (fr) Composes de porphyrine et compositions utiles pour le traitement du cancer
CA3018991C (fr) Composes induisant la degradation de proteines anti-apoptotiques de la famille bcl-2 et utilisation de ces derniers
HK1260703A1 (en) Compounds that induce degradation of anti-apoptotic bcl-2 family proteins and the uses thereof
HK1260703B (en) Compounds that induce degradation of anti-apoptotic bcl-2 family proteins and the uses thereof
RU2801811C1 (ru) Новое соединение и содержащая это соединение фармацевтическая композиция для предотвращения или лечения рака
US20210323933A1 (en) Piperazine-2,5-diones as tgf-beta inhibitors
AU2011219862B2 (en) Dimeric IAP inhibitors